跳至主要内容
临床试验/JPRN-UMIN000021426
JPRN-UMIN000021426已完成未知

Angiogenic Therapy Against Peripheral Arterial Disease with bone marrow derived MSC grown in platelet-rich plasma - ATPAD

ational Center for Global Health and Medicine0 个研究点目标入组 5 人开始时间: 2016年3月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
5

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • * The patient with remarkable short life expectancy * Patient with the past which is alcohol or drug dependence within 3 months of past * Patient with malignant neoplasms and the patient who has the past within 5 years * The patient who judged that there was a possibility of the malignant tumor * Patient with severe diabetic retinopathy * The patient who can't get informed consent * The patient who judged that he was unsuitable to this trial

研究者

发起方
ational Center for Global Health and Medicine

相似试验

Angiogenic Therapy Against Peripheral Arterial... | 临床试验